BrokerLens

Akums Drugs and Pharmaceuticals Limited IPO (AKUMS)

Status
Listed
Security type
Mainboard
Price band
Rs.646 to Rs.679
Final issue price
Rs 679
Issue size
Not disclosed
Bidding opens
30 July 2024
Bidding closes
1 August 2024
Listing date
6 August 2024

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Akums Drugs and Pharmaceuticals Limited IPO?

The Akums Drugs and Pharmaceuticals Limited IPO price band is Rs.646 to Rs.679 per share.

When does the Akums Drugs and Pharmaceuticals Limited IPO open and close?

Bidding opens 30 July 2024 and closes 1 August 2024.

Is the Akums Drugs and Pharmaceuticals Limited IPO a mainboard or SME issue?

Akums Drugs and Pharmaceuticals Limited is a mainboard IPO, listing on NSE's main board.

When did the Akums Drugs and Pharmaceuticals Limited IPO list?

Akums Drugs and Pharmaceuticals Limited listed on 6 August 2024.

Does this page show the grey market premium (GMP) for Akums Drugs and Pharmaceuticals Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Akums Drugs and Pharmaceuticals Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.